Medicol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Medicol

What is Medicol? Identity and Purpose

Property Description
Active ingredient Ibuprofen
Form Oral (Tablet, Capsule, Suspension)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Pain relief, fever reduction, inflammation management
Origin Synthetic (Propionic Acid Derivative)

Identity and Pharmacological Class

Medicol is a trade designation for a pharmaceutical preparation whose sole active ingredient is Ibuprofen. This medicine is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). Ibuprofen is chemically identified as a propionic acid derivative, a synthetic compound that distinguishes it from other NSAID groups, such as salicylates. Medicol, as a brand, is often positioned for broad public access, being widely available for oral administration in consumer-friendly dosage forms, including tablets, capsules, and a liquid oral suspension.


General Use and Confirmed Effects

The fundamental utility of Medicol is the provision of relief across a triad of common symptoms: general pain, elevated fever, and systemic inflammation. This capability gives the drug its inherent analgesic, antipyretic, and anti-inflammatory properties, recognized for easing acute discomfort. For instance, the medicine is commonly used to manage simple headaches or muscle soreness. The medicine is utilized for its anti-inflammatory effects, including the capability to reduce swelling and redness in the body. This systemic action helps restore a stable physical condition.

Regulatory References

  1. NSAIDs Properties
  2. Ibuprofen Solid Oral Form
  3. Ibuprofen Liquid Oral Form
  4. Ibuprofen Anti-inflammatory Effect (EMA)
  5. Ibuprofen Analgesic Property
  6. Ibuprofen Antipyretic Property
  7. Ibuprofen Anti-inflammatory Property

What side effects are possible with Medicol?

Adverse Reactions and Safety Profile for Medicol

This section outlines the possible side effects and safety considerations for Medicol, based strictly on documentation from authoritative government regulatory bodies such as the FDA, EMA, and national health agencies.

Adverse Reaction Classification

Adverse reactions are formally organized by regulatory authorities using standardized frequency categories and grouping them by the System-Organ-Class (SOC) affected. The reported frequencies range from Very Common (ge 1/10) and Common (ge 1/100 to <1/10) to Uncommon, Rare, and Very Rare (<1/10,000). The most common body systems involved, as documented in regulatory labels, typically include the gastrointestinal, nervous, and skin and subcutaneous tissue systems.

Serious Safety Events and Restrictions

Official regulatory documents specifically identify Serious Adverse Reactions, which are events deemed medically significant or life-threatening. The safety profile also mandates specific Contraindications, representing absolute restrictions on use, and formal Special Warnings and Precautions that require particular caution or monitoring. These restrictions may relate to pre-existing conditions or concurrent medication use.

Population-Specific Safety Considerations

The official safety information addresses specific populations, including warnings or restrictions for use during Pregnancy and Lactation, or for individuals with impaired Hepatic or Renal function. Additionally, safety patterns related to the duration of exposure may be documented, where certain risks are noted to increase or be monitored with long-term use.

These regulatory classifications provide the factual foundation for understanding the medicine's risk profile, establishing the frequency and nature of potential side effects, and defining the formal limitations for its safe use.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations of an overdose of Medicol (Ibuprofen) and the required emergency actions, as found in government regulatory labeling.

Documented Manifestations and Complications

System Official Signs and Symptoms
Central Nervous System (CNS) Drowsiness, lethargy, dizziness, headache, confusion, and, in severe cases, seizures or coma.
Gastrointestinal (GI) Nausea, vomiting, abdominal pain (epigastric), and the serious risk of severe GI bleeding, ulceration, or perforation.
Systemic/Metabolic Acute renal failure, metabolic acidosis, and hypotension (shock) are severe, documented outcomes.

Required Emergency Actions

Immediate medical attention is required for any suspected overdose. The official prescribing information mandates contacting emergency services or a Poison Control Center right away. Patients are required to receive symptomatic and supportive treatment, as no specific antidote is available.

Medical procedures, such as the use of activated charcoal or gastric lavage, may be considered by healthcare professionals to manage the overdose, depending on the time elapsed since ingestion. Official regulatory documents note that elderly patients and dehydrated children may be at heightened risk for severe complications.

Therapeutic Uses of Medicol

What Medicol Treats: Main Uses and Benefits

Medicol (Ibuprofen) is commonly used to provide foundational support for symptom management across domains where symptoms related to physical discomfort, systemic imbalance, or inflammatory states cause temporary strain. In line with its therapeutic profile, its utility is generally focused on offering supportive relief during episodes when symptoms may intensify.

It is applied across domains where additional symptomatic support is needed, primarily addressing symptom clusters that may appear suddenly or fluctuate. These include relief for common pain manifestations like headaches, acute toothache, and backache; managing elevated body temperature (fever) associated with seasonal illnesses; and easing the localized swelling, stiffness, and pain seen in conditions like osteoarthritis and rheumatoid arthritis.

Quick Fact: Used for managing Mild to Moderate Pain, Fever, and Inflammation

Medicol assists with maintaining a sense of stability when symptoms are more noticeable, helping patients cope more steadily with difficult episodes by easing the overall symptom load.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Medicol (Acetaminophen)

This section outlines the official, regulatory eligibility and restrictions for using Medicol, based on government-mandated labeling. It is not a guide for self-treatment.


Formal Contraindications (Must NOT Use)

Population Category Eligibility Status
Severe Hepatic Impairment / Active Liver Disease Contraindicated
Known Hypersensitivity (to acetaminophen or excipients) Contraindicated

Medicol is formally contraindicated in individuals with severe active liver disease and in those with a documented history of hypersensitivity (allergic reaction) to the drug or any of its components.

Use Requiring Caution or Restriction

Use of Medicol requires caution and clinical consideration in several populations due to the risk of toxicity or altered drug clearance. These conditions may necessitate dose adjustment or closer monitoring, and include:

  • Hepatic Impairment / Active Hepatic Disease (not severe)
  • Severe Renal Impairment (Creatinine Clearance le 30 mL/min)
  • Alcoholism or Chronic Malnutrition
  • Severe Hypovolemia

General Eligibility

The medication is generally indicated for use across adults, adolescents, and pediatric patients where proper age-appropriate dosing is followed. While safety during pregnancy requires individualized assessment, regulatory labeling indicates appropriate use has not been clearly associated with adverse outcomes.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Medicol (Ibuprofen) interacts with various medicines and substances, and the interaction profile is strictly defined in regulatory documents. Co-administration is formally contraindicated with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and high daily doses of Acetylsalicylic Acid (Aspirin, over 75 mg) due to an increased risk of serious gastrointestinal events. Additionally, use is prohibited in the peri-operative setting of coronary artery bypass graft (CABG) surgery.

Documented Interaction Outcomes

Interaction Type Interacting Substances Official Outcome/Restriction
Pharmacodynamic Anticoagulants, SSRIs, Oral Corticosteroids Increased risk of gastrointestinal bleeding/haemorrhage.
Pharmacokinetic Lithium, Methotrexate, Cardiac Glycosides Potential for increased plasma levels of the co-administered drug.
Interference Low-Dose Aspirin (Anti-platelet) May competitively inhibit the anti-platelet effect, requiring timing separation (e.g., eight hours before or 30 minutes after immediate-release aspirin).
Effect Reduction Antihypertensives (e.g., ACE inhibitors) Potential to diminish the blood pressure-lowering effect.

Co-administration with Diuretics or Immunosuppressants (Ciclosporin, Tacrolimus) increases the risk of nephrotoxicity. Regulatory documents note that these interactions, particularly those affecting renal function, are more significant in the elderly and dehydrated patients.

Mechanism of Action

Modulating Receptor-Mediated Signaling

Medicol acts within domains involving receptor- or enzyme-mediated signaling by initiating or suppressing specific signaling sequences. This mechanism modifies early molecular steps, which is relevant in cascades where multiple layers of pathway activation occur, resulting in the modulation of pathway equilibrium.


Regulating Heightened Physiological Responses

The drug's activity is focused on systems where specific transmitters or mediators dominate, engaging mechanisms that regulate overactive or dysregulated processes. This modulates key pathways associated with heightened physiological responses, reducing the concentration and activity of specific mediators and leading to defined physiological alterations.


Influencing Intracellular Pathway Cascades

Medicol influences feedback regulation by engaging mechanisms that modify early molecular steps that shape systemic physiological outcomes. This initiates or suppresses signaling sequences that lead to downstream effects, altering the signaling threshold of overactive physiological responses by adjusting pathway activity that may escalate under certain conditions.

Dosage and Administration Information

Administration Routes and Dosage

Medicol (Ibuprofen) is primarily administered via the oral route, available in forms such as tablets, capsules, and a liquid suspension. A parenteral intravenous form is also utilized in specific clinical settings for the management of pain and fever, administered after dilution.


Dosing Regimens and Schedules

Adult use adheres to defined dosing ranges. For acute use, single oral doses typically range from 200 mg to 400 mg, administered every 4 to 6 hours as required. The maximum recommended daily intake for over-the-counter use is 1,200 mg. For chronic conditions, the daily dose may be higher, administered in divided doses up to a maximum of 3,200 mg, though the lowest effective dose for the shortest duration is the standard procedural principle.


Procedural and Population Requirements

To improve tolerance, common practice includes taking Medicol with food or milk. The liquid oral suspension requires the container to be shaken well and the dose to be accurately measured using the provided device. Use is generally restricted to short-term duration (e.g., not more than 10 days for pain) unless prolonged use is professionally supervised. For pediatric patients, the dose calculation is based on body weight (5 to 10 mg/kg per dose), ensuring precise administration. If a dose is missed, the standard procedure is to skip it if it is near the next scheduled time, and not double the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Medicol


Evidence for Acute Relief of Mild to Moderate Pain

The research on Medicol's active ingredient was observed in studies examining patient-reported experiences and utilized a large body of short-term, randomized controlled trials (RCTs). These studies were relevant in trials assessing short-term or episodic symptom patterns, such as headaches or pain from minor musculoskeletal injuries. Researchers primarily focused on patient-reported outcomes describing perceived discomfort, specifically measuring changes in pain intensity over the first few hours after participants were given the drug.

Studies report how symptoms evolved in the observed populations, with findings describing patterns observed in the studies related to changes in measured pain scores at specific early time points. Follow-up durations were limited, meaning the reported outcomes were short-term, generally evaluated over the immediate 4 to 12 hours post-dosing. Data for certain groups with complex co-existing health conditions remain insufficient in the main body of this type of research.


️ Research Supporting Use for Fever Reduction

Research studied Medicol's use for fever, drawing from controlled clinical studies that monitor outcomes related to systemic or functional imbalance. These studies compared the active ingredient against placebo or other common fever-reducing agents. The key study outcomes examined were the magnitude of temperature change and the duration of the observed temperature pattern in the populations studied.

Comparative studies examined patterns related to reaching a defined temperature threshold when compared with non-active controls or standard antipyretic therapies. While research provides context, long-term effects are not fully established since follow-up durations were limited to the acute period of fever, often less than 48 hours. Data for infants younger than six months of age remain insufficient for establishing a broad research pattern in this age group.


Evidence Base for Chronic Inflammatory Conditions

Medicol was also studied for conditions marked by functional limitations, such as rheumatoid arthritis and osteoarthritis. Research utilized studies involving intermediate- to long-term randomized controlled trials and observational cohorts that examined daily-life functioning. The studies monitored outcomes reflecting daily functioning or activity level, specifically using tools to measure changes in joint stiffness and functional capacity compared to baseline. Findings indicate patterns related to measured changes in physical discomfort that were observed throughout the study periods.

Key Studies & References Ibuprofen Drug Information (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Medicol (FAQ)

Q: How does Medicol (Ibuprofen) actually work to lower a fever?

Medicol (Ibuprofen) is known to lower a fever by affecting certain natural chemicals in the body called prostaglandins. These prostaglandins are natural chemical mediators involved in the body’s inflammatory, pain, and fever responses. Official information suggests the drug's activity helps reduce the production of these chemicals, leading to a decrease in body temperature.


Q: What is the main difference between taking an oral tablet versus the intravenous form of Medicol?

The oral forms of Medicol, such as tablets and capsules, are the primary methods of administration and are widely available for pain and fever management. According to regulatory documents, the intravenous form is specifically approved for use in certain clinical settings, such as hospital environments, when oral administration is not appropriate.


Q: What should I do if I miss a scheduled dose of the liquid suspension?

Official dosing instructions state that if a dose is missed and it is near the time for the next scheduled dose, the patient should skip the missed dose. It is generally advised not to take a double dose to make up for the dose that was missed.


Q: What should I look out for as the earliest or mildest signs of an allergic reaction to Medicol?

Official drug facts warn that Medicol may cause a severe allergic reaction. Signs to watch for include hives, facial swelling, skin reddening, rash, and blisters. If any signs of a severe allergic reaction are observed, official guidelines state that immediate medical attention should be sought.


Q: Is Medicol a narcotic or does it cause addiction?

Medicol, which contains Ibuprofen, is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is used as a non-opioid pain reliever. It is not categorized as a narcotic, which is the term commonly used to describe opioid medications.

How should Medicol be stored and disposed of?

Official Storage and Disposal Requirements

Storage Conditions

Medicol (Ibuprofen) must be stored at controlled room temperature, typically defined by regulators as below 25 C or 30 C. It is mandatory to keep the product in its original container, which must be tightly closed and protected from both moisture and light. The medicine must not be frozen. As a critical safety requirement, all medicinal products must be stored out of the sight and reach of children.

Disposal Procedures

Expired or unused Medicol should be disposed of in accordance with local regulations. The official recommended method is utilizing a drug take-back program or authorized collection point. If a take-back program is unavailable, the medicine should be mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed container before discarding it in the household trash. The product must not be flushed down a toilet or drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Medicol found in:

A-Z Index: